Satoshi Dote

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Combination Therapy

Multiple Myeloma

Methicillin Resistant Staphylococcus Aureus

Acute Kidney Injury

Top Venues

Hematological oncology

Leukemia & lymphoma

Journal of pharmaceutical health care and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Azusa Kariya, Hiroshi Okada, Shota Suzuki, Satoshi Dote, Yoshitaka Nishikawa, Kazuo Araki, Yoshimitsu Takahashi, Takeo Nakayama
Internet-Based Inquiries From Users With the Intention to Overdose With Over-the-Counter Drugs: Qualitative Analysis of Yahoo! Chiebukuro. JMIR formative research 7 (2023)
Satoshi Dote, PhD Ryo Inose, Ryota Goto, Yuka Kobayashi, Yuichi Muraki
Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database. Hematological oncology (2023)
Satoshi Dote, Eiji Shiwaku, Emiko Kohno, Ryohei Fujii, Keiji Mashimo, Naomi Morimoto, Masaki Yoshino, Naoki Odaira, Hiroaki Ikesue, Masaki Hirabatake, Katsuyuki Takahashi, Masaya Takahashi, Mari Takagi, Satoshi Nishiuma, Kaori Ito, Akane Shimato, Shoji Itakura, Yoshitaka Takahashi, Yutaka Negoro, Mina Shigemori, Hiroyuki Watanabe, Dai Hayasaka, Masahiko Nakao, Misaki Tasaka, Emi Goto, Noriaki Kataoka, Ayako Yokomizo, Ayako Kobayashi, Yoko Nakata, Mafumi Miyake, Yaeko Hayashi, Yoshie Yamamoto, Taiki Hirata, Kanako Azuma, Katsuya Makihara, Rino Fukui, Akira Tokutome, Keiji Yagisawa, Shinji Honda, Yuji Meguro, Shota Suzuki, Daisuke Yamaguchi, Hitomi Miyata, Yuka Kobayashi, null null
Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study. International journal of clinical oncology (2023)
Satoshi Dote, Ryo Inose, Ryota Goto, Yuka Kobayashi, Yuichi Muraki
Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database. Hematological oncology (2023)
Eiji Shiwaku, Satoshi Dote, Shinobu Kaneko, Chisato Hei, Masaki Aikawa, Yuki Sakai, Takahiro Kawai, Shigeaki Iwatsubo, Michinobu Hashimoto, Teppei Tsuneishi, Tomoko Nishimura, Toshiyuki Iwata, Daiki Hira, Tomohiro Terada, Takashi Nishimura, Yuka Kobayashi
Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study. Journal of pharmaceutical health care and sciences 7 (1) (2021)
Kohei Sazanami, Ryo Inose, Satoshi Dote, Nozomu Horiuchi, Yuka Kobayashi, Yuichi Muraki
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration. Journal of chemotherapy (Florence, Italy) 33 (6) (2020)
Satoshi Dote, Kaori Ito, Shoji Itakura, Takeo Yasu, Daiki Hira, Satoshi Noda, Shigeki Yamada, Yuka Kobayashi, Tomohiro Terada
Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort study. Leukemia & lymphoma 60 (12) (2019)
Satoshi Dote, Shoji Itakura, Kohei Kamei, Daiki Hira, Satoshi Noda, Yuka Kobayashi, Tomohiro Terada
Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study. BMC cancer 18 (1) (2018)